Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study.

autism spectrum disorder cognition endophenotype psychosocial functioning schizophrenia first-degree relatives social cognition

Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
23 10 2023
Historique:
medline: 14 11 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: epublish

Résumé

Autistic symptoms represent a frequent feature in schizophrenia spectrum disorders (SSD). However, the prevalence and the cognitive and functional correlates of autistic symptoms in unaffected first-degree relatives of people with SSD remain to be assessed. A total of 342 unaffected first-degree relatives related to 247 outpatients with schizophrenia were recruited as part of the multicenter study of the Italian Network for Research on Psychoses (NIRP). Autistic features were measured with the PANSS Autism Severity Scale. Three groups of participants, defined on the presence and severity of autistic symptoms, were compared on a wide array of cognitive and functional measures. Of the total sample, 44.9% presented autistic symptoms; 22.8% showed moderate levels of autistic symptoms, which can be observed in the majority of people with SSD. Participants with higher levels of autistic symptoms showed worse performance on Working Memory ( A high prevalence of autistic symptoms was observed in first-degree relatives of people with SSD. Autistic symptoms severity showed a negative correlation with cognitive performance and functional outcomes also in this population and may represent a diagnostic and treatment target of considerable scientific and clinical interest in both patients and their first-degree relatives.

Sections du résumé

BACKGROUND
Autistic symptoms represent a frequent feature in schizophrenia spectrum disorders (SSD). However, the prevalence and the cognitive and functional correlates of autistic symptoms in unaffected first-degree relatives of people with SSD remain to be assessed.
METHODS
A total of 342 unaffected first-degree relatives related to 247 outpatients with schizophrenia were recruited as part of the multicenter study of the Italian Network for Research on Psychoses (NIRP). Autistic features were measured with the PANSS Autism Severity Scale. Three groups of participants, defined on the presence and severity of autistic symptoms, were compared on a wide array of cognitive and functional measures.
RESULTS
Of the total sample, 44.9% presented autistic symptoms; 22.8% showed moderate levels of autistic symptoms, which can be observed in the majority of people with SSD. Participants with higher levels of autistic symptoms showed worse performance on Working Memory (
CONCLUSIONS
A high prevalence of autistic symptoms was observed in first-degree relatives of people with SSD. Autistic symptoms severity showed a negative correlation with cognitive performance and functional outcomes also in this population and may represent a diagnostic and treatment target of considerable scientific and clinical interest in both patients and their first-degree relatives.

Identifiants

pubmed: 37869966
doi: 10.1192/j.eurpsy.2023.2455
pii: S0924933823024550
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e85

Auteurs

Antonio Vita (A)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.

Stefano Barlati (S)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.

Giacomo Deste (G)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.

Alessandro Rossi (A)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Paola Rocca (P)

Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.

Alessandro Bertolino (A)

Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.

Eugenio Aguglia (E)

Department of Clinical and Molecular Biomedicine, Psychiatry Unit, University of Catania, Catania, Italy.

Carlo A Altamura (CA)

Department of Psychiatry, University of Milan, Milan, Italy.

Mario Amore (M)

Section of Psychiatry, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.

Antonello Bellomo (A)

Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.

Paola Bucci (P)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Bernardo Carpiniello (B)

Section of Psychiatry, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.

Alessandro Cuomo (A)

Department of Molecular Medicine and Clinical Department of Mental Health, University of Siena, Siena, Italy.

Liliana Dell'Osso (L)

Section of Psychiatry, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Luigi Giuliani (L)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Carlo Marchesi (C)

Department of Neuroscience, Psychiatry Unit, University of Parma, Parma, Italy.

Giovanni Martinotti (G)

Department of Neuroscience and Imaging, G. d'Annunzio University, Chieti, Italy.

Palmiero Monteleone (P)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Cristiana Montemagni (C)

Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.

Gabriele Nibbio (G)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.

Massimo Pasquini (M)

Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Maurizio Pompili (M)

Department of Neurosciences, Mental Health and Sensory Organs, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Antonio Rampino (A)

Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.

Rita Roncone (R)

Unit of Psychiatry, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Rodolfo Rossi (R)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alberto Siracusano (A)

Department of Systems Medicine, Psychiatry and Clinical Psychology Unit, Tor Vergata University of Rome, Rome, Italy.

Elena Tenconi (E)

Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy.

Patrizia Zeppegno (P)

Department of Translational Medicine, Psychiatric Unit, University of Eastern Piedmont, Novara, Italy.

Silvana Galderisi (S)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Mario Maj (M)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH